Two LifeSphere Safety products–MultiVigilance and Reporting and Analytics–are powering PMI’s pharmacovigilance efficiencies in multiple languages with automation and machine learning. MIAMI, FL — June 16, 2022 — ArisGlobal, the leading provider of life sciences...
LifeSphere Safety: Extending a Worldwide Pharmacovigilance Program to the Japanese Market
ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture.